Stockscreener 앱 받기
1.555
59.29%
-2.265
시간 외 거래:
1.63
0.075
+4.82%
전일 마감가:
$3.82
열려 있는:
$1.79
하루 거래량:
14.99M
Relative Volume:
75.88
시가총액:
$3.23M
수익:
-
순이익/손실:
$-20.26M
주가수익비율:
-0.1821
EPS:
-8.54
순현금흐름:
$-8.25M
1주 성능:
-56.93%
1개월 성능:
-56.81%
6개월 성능:
-85.96%
1년 성능:
-95.11%
1일 변동 폭
$1.54
$1.80
1주일 범위
$1.54
$4.19
52주 변동 폭
$1.54
$75.60
Oragenics Inc Stock (OGEN) Company Profile
명칭
Oragenics Inc
전화
813-286-7900
주소
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
OGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.555 | 3.23M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.67 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Oragenics Inc 주식(OGEN)의 최신 뉴스
Major Shareholder Odyssey Health Sells Oragenics Stock! - TipRanks
Future of Oral Probiotic Supplements | Innovations in Oral - openPR.com
Oragenics Inc. to Showcase Concussion Treatment Candidate at Major 2025 Conferences - citybuzz -
Oragenics to Present at 2025 BIO International Convention and At - GuruFocus
Oragenics, Inc. to Present ONP-002 at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Nasdaq
GlobeNewswire by Notified - The Manila Times
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium | OGEN Stock News - GuruFocus
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - The Manila Times
Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews
Oragenics to Present at 2025 BIO International Convention - GlobeNewswire
Top stock gains: US stocks posting the highest gains today - Yahoo
Rocket Lab Corporation (RKLB): A Bull Case Theory - Yahoo
Upstart Holdings, Inc. (UPST): A Bull Case Theory - Yahoo
Vireo Growth Inc. Announces Closing of Proper Brands Acquisition in Missouri - Yahoo
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea - Yahoo
Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews
Top Premarket Decliners - MarketScreener
Oragenics (OGEN) Resumes Trading: Key Insights for Investors | O - GuruFocus
Oragenics (OGEN) Trading Paused Due to High Volatility | OGEN St - GuruFocus
Oragenics (OGEN) Resumes Trading: Key Insights for Investors | OGEN Stock News - GuruFocus
ABB acquires Bel Products Inc. to expand enclosures portfolio in North America - Yahoo
Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews
Oral Probiotics Supplements Gain Popularity in Digestive - openPR.com
OGEN stock touches 52-week low at $0.12 amid sharp annual decline By Investing.com - Investing.com South Africa
OGEN stock touches 52-week low at $0.12 amid sharp annual decline - Investing.com Australia
Oragenics announces reverse stock split to begin June 3 By Investing.com - Investing.com South Africa
Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews
Oragenics (OGEN) Announces One-for-Thirty Reverse Stock Split | - GuruFocus
Oragenics announces reverse stock split to begin June 3 - Investing.com Australia
Oragenics Announces Reverse Stock Split to Boost Share Price - TipRanks
Oragenics (OGEN) Announces One-for-Thirty Reverse Stock Split | OGEN Stock News - GuruFocus
Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split - GlobeNewswire
Worksport Secures ISO 9001 Certification at U.S. Factory, Unlocking Revenue & OEM Growth Pathways - The Manila Times
Oragenics Hosts Neurotrauma Medicine Webinar Presentation - TipRanks
Oragenics (NYSE:OGEN) Earns Sell Rating from Analysts at StockNews.com - Defense World
Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia - GlobeNewswire
TotalEnergies sells 50% stake in Polish biogas company to HitecVision - Yahoo
Oragenics (OGEN) Gains Approval for Phase II Trial of Neuroprote - GuruFocus
Oragenics gains Australia’s nod for concussion therapy trial - Investing.com Australia
Oragenics gains Australia’s nod for concussion therapy trial By Investing.com - Investing.com Nigeria
Oragenics, Inc. Announces Approval to Initiate Phase II Concussi - GuruFocus
Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia | OGEN Stock News - GuruFocus
Oragenics, Inc. to Host Management Update Webinar on May - GlobeNewswire
Oragenics, Inc. to Host Management Update Webinar on May 20, 202 - GuruFocus
Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision | OGEN Stock News - GuruFocus
Oragenics, Inc. to Host Webinar on ONP-002 and Addressing Unmet Needs in Concussion Treatment - Nasdaq
CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2025 Earnings Release Conference Call - The Manila Times
Oragenics: Q1 Earnings Snapshot - New Haven Register
Oragenics Inc (OGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Oragenics Inc 주식 (OGEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Odyssey Health, Inc. | 10% Owner |
Jun 17 '25 |
Sale |
4.46 |
2,000 |
8,920 |
5,044 |
| Odyssey Health, Inc. | 10% Owner |
Jun 16 '25 |
Sale |
4.45 |
5,000 |
22,250 |
7,044 |
| Odyssey Health, Inc. | 10% Owner |
Jun 13 '25 |
Sale |
4.27 |
5,000 |
21,350 |
12,044 |
0.27%
0.50%
자본화:
|
볼륨(24시간):